G65471CD
| Organisms | Evidence |
|---|---|
| Campylobacter jejuni |
RES 1b:b-dgal-HEX-1:5 2b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 3s:n-acetyl 4b:b-dgal-HEX-1:5 5s:n-acetyl 6b:b-dgal-HEX-1:5 7b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 8s:n-acetyl 9b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 10s:n-acetyl LIN 1:1o(3+2)2d 2:2d(5+1)3n 3:1o(4+1)4d 4:4d(2+1)5n 5:4o(3+1)6d 6:6o(3+2)7d 7:7d(5+1)8n 8:7o(8+2)9d 9:9d(5+1)10n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 26474293 | Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity | Buch MHC | 2015 Oct 16 |
|
| 12183547 | Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides inCampylobacter jejuniStrains Associated with Guillain-BarreĢ Syndrome | Bowes T | 2002 Sep |
|
| 10491405 | Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations | Goodyear CS | 1999 Sep |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025